Skip to content

NA RFK-C101020VZRecalls & reported problems

Boston Scientific Neuromodulation Corporation · Cannula, 10cm,10mm tip,20G Sharp Curved · Class 2

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00813250016888), received between Apr 6, 2018 and Apr 6, 2018 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Hypersensitivity/Allergic reaction1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryApr 6, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A REPORT WAS RECEIVED THAT A PATIENT DEVELOPED TEMPORARY WEALS AT THE CANNULA INSERTION SITES A WEEK AFTER THE PROCEDURE. THE PATIENT'S SKIN WAS ITCHY. THE PHYSICIAN SAYS IT APPEARS TO BE TYPE 4 (DELAYED SKIN IMMUNE CELL MEDIATED) HYPERSENSITIVITY RESPONSE. IT IS UNKNOWN IF ANY MEDICAL INTERVENTION WAS PERFORMED. THE PHYSICIAN PREPPED THE PATIENT'S SKIN WITH CHLORAPREP. THE PHYSICIAN IS UNSURE, BUT BELIEVES IT IS POSSIBLE THAT CHLORAPREP COULD BE THE CAUSE OR THE CAUSE COULD BE THE CANNULAS.

    Patient problems: Hypersensitivity/Allergic reaction

    MAUDE report 7403348 ↗

Other PROBE, RADIOFREQUENCY LESION devices

All PROBE, RADIOFREQUENCY LESION devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page